nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—rheumatoid arthritis—psoriatic arthritis	0.342	0.544	CtDrD
Cyclosporine—psoriasis—psoriatic arthritis	0.287	0.456	CtDrD
Cyclosporine—ABCC10—Methotrexate—psoriatic arthritis	0.0288	0.101	CbGbCtD
Cyclosporine—SLCO1A2—Prednisolone—psoriatic arthritis	0.021	0.0735	CbGbCtD
Cyclosporine—SLCO1A2—Prednisone—psoriatic arthritis	0.0198	0.0694	CbGbCtD
Cyclosporine—ABCB11—Dexamethasone—psoriatic arthritis	0.0195	0.0683	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—psoriatic arthritis	0.0181	0.0635	CbGbCtD
Cyclosporine—SLCO1A2—Dexamethasone—psoriatic arthritis	0.0124	0.0433	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—psoriatic arthritis	0.0111	0.039	CbGbCtD
Cyclosporine—ABCC2—Dexamethasone—psoriatic arthritis	0.0102	0.0359	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—psoriatic arthritis	0.00993	0.0348	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—psoriatic arthritis	0.00937	0.0328	CbGbCtD
Cyclosporine—ABCG2—Dexamethasone—psoriatic arthritis	0.00926	0.0325	CbGbCtD
Cyclosporine—ABCB1—Methylprednisolone—psoriatic arthritis	0.00883	0.031	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—psoriatic arthritis	0.00823	0.0289	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—psoriatic arthritis	0.00744	0.0261	CbGbCtD
Cyclosporine—CYP3A7—Dexamethasone—psoriatic arthritis	0.00684	0.024	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.00684	0.024	CbGbCtD
Cyclosporine—CYP2C19—Prednisone—psoriatic arthritis	0.00663	0.0232	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—psoriatic arthritis	0.00602	0.0211	CbGbCtD
Cyclosporine—ABCB1—Betamethasone—psoriatic arthritis	0.00574	0.0201	CbGbCtD
Cyclosporine—ABCB1—Prednisolone—psoriatic arthritis	0.00566	0.0199	CbGbCtD
Cyclosporine—ABCB1—Prednisone—psoriatic arthritis	0.00535	0.0188	CbGbCtD
Cyclosporine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.00529	0.0185	CbGbCtD
Cyclosporine—CYP3A5—Dexamethasone—psoriatic arthritis	0.00513	0.018	CbGbCtD
Cyclosporine—CYP2C8—Dexamethasone—psoriatic arthritis	0.00493	0.0173	CbGbCtD
Cyclosporine—CYP2C19—Dexamethasone—psoriatic arthritis	0.00414	0.0145	CbGbCtD
Cyclosporine—CYP3A4—Triamcinolone—psoriatic arthritis	0.00401	0.0141	CbGbCtD
Cyclosporine—CYP2C9—Dexamethasone—psoriatic arthritis	0.00344	0.0121	CbGbCtD
Cyclosporine—CYP3A4—Betamethasone—psoriatic arthritis	0.00344	0.0121	CbGbCtD
Cyclosporine—CYP3A4—Prednisolone—psoriatic arthritis	0.00339	0.0119	CbGbCtD
Cyclosporine—ABCB1—Dexamethasone—psoriatic arthritis	0.00334	0.0117	CbGbCtD
Cyclosporine—CYP3A4—Prednisone—psoriatic arthritis	0.0032	0.0112	CbGbCtD
Cyclosporine—CYP2D6—Dexamethasone—psoriatic arthritis	0.00315	0.011	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—psoriatic arthritis	0.00268	0.00941	CbGbCtD
Cyclosporine—CYP3A4—Dexamethasone—psoriatic arthritis	0.002	0.00701	CbGbCtD
Cyclosporine—Discomfort—Methylprednisolone—psoriatic arthritis	6.02e-05	0.000705	CcSEcCtD
Cyclosporine—Dry mouth—Triamcinolone—psoriatic arthritis	5.97e-05	0.000699	CcSEcCtD
Cyclosporine—Renal failure—Methotrexate—psoriatic arthritis	5.96e-05	0.000697	CcSEcCtD
Cyclosporine—Angioedema—Betamethasone—psoriatic arthritis	5.95e-05	0.000696	CcSEcCtD
Cyclosporine—Angioedema—Dexamethasone—psoriatic arthritis	5.95e-05	0.000696	CcSEcCtD
Cyclosporine—Stomatitis—Methotrexate—psoriatic arthritis	5.91e-05	0.000692	CcSEcCtD
Cyclosporine—Angiopathy—Prednisone—psoriatic arthritis	5.91e-05	0.000691	CcSEcCtD
Cyclosporine—Conjunctivitis—Methotrexate—psoriatic arthritis	5.89e-05	0.00069	CcSEcCtD
Cyclosporine—Confusional state—Methylprednisolone—psoriatic arthritis	5.89e-05	0.000689	CcSEcCtD
Cyclosporine—Malaise—Dexamethasone—psoriatic arthritis	5.87e-05	0.000687	CcSEcCtD
Cyclosporine—Malaise—Betamethasone—psoriatic arthritis	5.87e-05	0.000687	CcSEcCtD
Cyclosporine—Oedema—Triamcinolone—psoriatic arthritis	5.85e-05	0.000685	CcSEcCtD
Cyclosporine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	5.85e-05	0.000685	CcSEcCtD
Cyclosporine—Vertigo—Dexamethasone—psoriatic arthritis	5.85e-05	0.000684	CcSEcCtD
Cyclosporine—Vertigo—Betamethasone—psoriatic arthritis	5.85e-05	0.000684	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	5.84e-05	0.000684	CcSEcCtD
Cyclosporine—Arrhythmia—Prednisone—psoriatic arthritis	5.82e-05	0.000681	CcSEcCtD
Cyclosporine—Infection—Triamcinolone—psoriatic arthritis	5.82e-05	0.000681	CcSEcCtD
Cyclosporine—Infection—Methylprednisolone—psoriatic arthritis	5.8e-05	0.000679	CcSEcCtD
Cyclosporine—Haematuria—Methotrexate—psoriatic arthritis	5.78e-05	0.000676	CcSEcCtD
Cyclosporine—Insomnia—Prednisolone—psoriatic arthritis	5.76e-05	0.000674	CcSEcCtD
Cyclosporine—Alopecia—Prednisone—psoriatic arthritis	5.75e-05	0.000673	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	5.73e-05	0.000671	CcSEcCtD
Cyclosporine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	5.73e-05	0.00067	CcSEcCtD
Cyclosporine—Epistaxis—Methotrexate—psoriatic arthritis	5.72e-05	0.000669	CcSEcCtD
Cyclosporine—Paraesthesia—Prednisolone—psoriatic arthritis	5.72e-05	0.000669	CcSEcCtD
Cyclosporine—Mental disorder—Prednisone—psoriatic arthritis	5.7e-05	0.000668	CcSEcCtD
Cyclosporine—Skin disorder—Methylprednisolone—psoriatic arthritis	5.67e-05	0.000664	CcSEcCtD
Cyclosporine—Malnutrition—Prednisone—psoriatic arthritis	5.67e-05	0.000663	CcSEcCtD
Cyclosporine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	5.66e-05	0.000662	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	5.65e-05	0.000661	CcSEcCtD
Cyclosporine—Convulsion—Dexamethasone—psoriatic arthritis	5.64e-05	0.00066	CcSEcCtD
Cyclosporine—Convulsion—Betamethasone—psoriatic arthritis	5.64e-05	0.00066	CcSEcCtD
Cyclosporine—Hypertension—Dexamethasone—psoriatic arthritis	5.62e-05	0.000658	CcSEcCtD
Cyclosporine—Hypertension—Betamethasone—psoriatic arthritis	5.62e-05	0.000658	CcSEcCtD
Cyclosporine—Myalgia—Betamethasone—psoriatic arthritis	5.54e-05	0.000649	CcSEcCtD
Cyclosporine—Myalgia—Dexamethasone—psoriatic arthritis	5.54e-05	0.000649	CcSEcCtD
Cyclosporine—Anxiety—Betamethasone—psoriatic arthritis	5.52e-05	0.000646	CcSEcCtD
Cyclosporine—Anxiety—Dexamethasone—psoriatic arthritis	5.52e-05	0.000646	CcSEcCtD
Cyclosporine—Discomfort—Dexamethasone—psoriatic arthritis	5.47e-05	0.000641	CcSEcCtD
Cyclosporine—Discomfort—Betamethasone—psoriatic arthritis	5.47e-05	0.000641	CcSEcCtD
Cyclosporine—Haemoglobin—Methotrexate—psoriatic arthritis	5.47e-05	0.00064	CcSEcCtD
Cyclosporine—Pain—Prednisolone—psoriatic arthritis	5.44e-05	0.000637	CcSEcCtD
Cyclosporine—Haemorrhage—Methotrexate—psoriatic arthritis	5.44e-05	0.000637	CcSEcCtD
Cyclosporine—Hepatitis—Methotrexate—psoriatic arthritis	5.44e-05	0.000637	CcSEcCtD
Cyclosporine—Pharyngitis—Methotrexate—psoriatic arthritis	5.4e-05	0.000632	CcSEcCtD
Cyclosporine—Urinary tract disorder—Methotrexate—psoriatic arthritis	5.37e-05	0.000629	CcSEcCtD
Cyclosporine—Vision blurred—Prednisone—psoriatic arthritis	5.34e-05	0.000625	CcSEcCtD
Cyclosporine—Urethral disorder—Methotrexate—psoriatic arthritis	5.33e-05	0.000624	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	5.33e-05	0.000624	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	5.32e-05	0.000623	CcSEcCtD
Cyclosporine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	5.31e-05	0.000622	CcSEcCtD
Cyclosporine—Anaphylactic shock—Betamethasone—psoriatic arthritis	5.31e-05	0.000622	CcSEcCtD
Cyclosporine—Oedema—Dexamethasone—psoriatic arthritis	5.31e-05	0.000622	CcSEcCtD
Cyclosporine—Oedema—Betamethasone—psoriatic arthritis	5.31e-05	0.000622	CcSEcCtD
Cyclosporine—Insomnia—Triamcinolone—psoriatic arthritis	5.29e-05	0.00062	CcSEcCtD
Cyclosporine—Insomnia—Methylprednisolone—psoriatic arthritis	5.28e-05	0.000618	CcSEcCtD
Cyclosporine—Infection—Betamethasone—psoriatic arthritis	5.28e-05	0.000618	CcSEcCtD
Cyclosporine—Infection—Dexamethasone—psoriatic arthritis	5.28e-05	0.000618	CcSEcCtD
Cyclosporine—Ill-defined disorder—Prednisone—psoriatic arthritis	5.26e-05	0.000616	CcSEcCtD
Cyclosporine—Paraesthesia—Triamcinolone—psoriatic arthritis	5.26e-05	0.000615	CcSEcCtD
Cyclosporine—Feeling abnormal—Prednisolone—psoriatic arthritis	5.25e-05	0.000614	CcSEcCtD
Cyclosporine—Paraesthesia—Methylprednisolone—psoriatic arthritis	5.24e-05	0.000614	CcSEcCtD
Cyclosporine—Visual impairment—Methotrexate—psoriatic arthritis	5.24e-05	0.000614	CcSEcCtD
Cyclosporine—Anaemia—Prednisone—psoriatic arthritis	5.24e-05	0.000613	CcSEcCtD
Cyclosporine—Dyspnoea—Triamcinolone—psoriatic arthritis	5.22e-05	0.000611	CcSEcCtD
Cyclosporine—Nervous system disorder—Betamethasone—psoriatic arthritis	5.21e-05	0.00061	CcSEcCtD
Cyclosporine—Nervous system disorder—Dexamethasone—psoriatic arthritis	5.21e-05	0.00061	CcSEcCtD
Cyclosporine—Agitation—Prednisone—psoriatic arthritis	5.21e-05	0.00061	CcSEcCtD
Cyclosporine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	5.2e-05	0.000609	CcSEcCtD
Cyclosporine—Thrombocytopenia—Betamethasone—psoriatic arthritis	5.2e-05	0.000609	CcSEcCtD
Cyclosporine—Angioedema—Prednisone—psoriatic arthritis	5.18e-05	0.000606	CcSEcCtD
Cyclosporine—Dyspepsia—Triamcinolone—psoriatic arthritis	5.15e-05	0.000603	CcSEcCtD
Cyclosporine—Dyspepsia—Methylprednisolone—psoriatic arthritis	5.14e-05	0.000602	CcSEcCtD
Cyclosporine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	5.13e-05	0.000601	CcSEcCtD
Cyclosporine—Hyperhidrosis—Betamethasone—psoriatic arthritis	5.13e-05	0.000601	CcSEcCtD
Cyclosporine—Malaise—Prednisone—psoriatic arthritis	5.11e-05	0.000598	CcSEcCtD
Cyclosporine—Vertigo—Prednisone—psoriatic arthritis	5.09e-05	0.000596	CcSEcCtD
Cyclosporine—Tinnitus—Methotrexate—psoriatic arthritis	5.07e-05	0.000594	CcSEcCtD
Cyclosporine—Anorexia—Dexamethasone—psoriatic arthritis	5.06e-05	0.000593	CcSEcCtD
Cyclosporine—Anorexia—Betamethasone—psoriatic arthritis	5.06e-05	0.000593	CcSEcCtD
Cyclosporine—Urticaria—Prednisolone—psoriatic arthritis	5.06e-05	0.000592	CcSEcCtD
Cyclosporine—Fatigue—Triamcinolone—psoriatic arthritis	5.05e-05	0.000591	CcSEcCtD
Cyclosporine—Fatigue—Methylprednisolone—psoriatic arthritis	5.04e-05	0.000589	CcSEcCtD
Cyclosporine—Pain—Triamcinolone—psoriatic arthritis	5.01e-05	0.000586	CcSEcCtD
Cyclosporine—Angiopathy—Methotrexate—psoriatic arthritis	4.94e-05	0.000578	CcSEcCtD
Cyclosporine—Convulsion—Prednisone—psoriatic arthritis	4.91e-05	0.000575	CcSEcCtD
Cyclosporine—Mediastinal disorder—Methotrexate—psoriatic arthritis	4.9e-05	0.000574	CcSEcCtD
Cyclosporine—Hypertension—Prednisone—psoriatic arthritis	4.89e-05	0.000573	CcSEcCtD
Cyclosporine—Chills—Methotrexate—psoriatic arthritis	4.88e-05	0.000571	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	4.84e-05	0.000566	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	4.84e-05	0.000566	CcSEcCtD
Cyclosporine—Myalgia—Prednisone—psoriatic arthritis	4.83e-05	0.000565	CcSEcCtD
Cyclosporine—Arthralgia—Prednisone—psoriatic arthritis	4.83e-05	0.000565	CcSEcCtD
Cyclosporine—Feeling abnormal—Triamcinolone—psoriatic arthritis	4.82e-05	0.000565	CcSEcCtD
Cyclosporine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	4.81e-05	0.000563	CcSEcCtD
Cyclosporine—Anxiety—Prednisone—psoriatic arthritis	4.81e-05	0.000563	CcSEcCtD
Cyclosporine—Alopecia—Methotrexate—psoriatic arthritis	4.81e-05	0.000563	CcSEcCtD
Cyclosporine—Insomnia—Dexamethasone—psoriatic arthritis	4.8e-05	0.000562	CcSEcCtD
Cyclosporine—Insomnia—Betamethasone—psoriatic arthritis	4.8e-05	0.000562	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	4.79e-05	0.000561	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	4.78e-05	0.000559	CcSEcCtD
Cyclosporine—Paraesthesia—Betamethasone—psoriatic arthritis	4.77e-05	0.000558	CcSEcCtD
Cyclosporine—Paraesthesia—Dexamethasone—psoriatic arthritis	4.77e-05	0.000558	CcSEcCtD
Cyclosporine—Discomfort—Prednisone—psoriatic arthritis	4.77e-05	0.000558	CcSEcCtD
Cyclosporine—Mental disorder—Methotrexate—psoriatic arthritis	4.77e-05	0.000558	CcSEcCtD
Cyclosporine—Malnutrition—Methotrexate—psoriatic arthritis	4.74e-05	0.000554	CcSEcCtD
Cyclosporine—Hypersensitivity—Prednisolone—psoriatic arthritis	4.69e-05	0.000549	CcSEcCtD
Cyclosporine—Dyspepsia—Dexamethasone—psoriatic arthritis	4.68e-05	0.000547	CcSEcCtD
Cyclosporine—Dyspepsia—Betamethasone—psoriatic arthritis	4.68e-05	0.000547	CcSEcCtD
Cyclosporine—Urticaria—Triamcinolone—psoriatic arthritis	4.65e-05	0.000544	CcSEcCtD
Cyclosporine—Urticaria—Methylprednisolone—psoriatic arthritis	4.64e-05	0.000543	CcSEcCtD
Cyclosporine—Dysgeusia—Methotrexate—psoriatic arthritis	4.64e-05	0.000543	CcSEcCtD
Cyclosporine—Body temperature increased—Triamcinolone—psoriatic arthritis	4.63e-05	0.000542	CcSEcCtD
Cyclosporine—Anaphylactic shock—Prednisone—psoriatic arthritis	4.63e-05	0.000541	CcSEcCtD
Cyclosporine—Oedema—Prednisone—psoriatic arthritis	4.63e-05	0.000541	CcSEcCtD
Cyclosporine—Abdominal pain—Methylprednisolone—psoriatic arthritis	4.62e-05	0.00054	CcSEcCtD
Cyclosporine—Decreased appetite—Dexamethasone—psoriatic arthritis	4.62e-05	0.00054	CcSEcCtD
Cyclosporine—Decreased appetite—Betamethasone—psoriatic arthritis	4.62e-05	0.00054	CcSEcCtD
Cyclosporine—Infection—Prednisone—psoriatic arthritis	4.6e-05	0.000538	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	4.59e-05	0.000537	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	4.59e-05	0.000537	CcSEcCtD
Cyclosporine—Fatigue—Betamethasone—psoriatic arthritis	4.58e-05	0.000536	CcSEcCtD
Cyclosporine—Fatigue—Dexamethasone—psoriatic arthritis	4.58e-05	0.000536	CcSEcCtD
Cyclosporine—Pain—Dexamethasone—psoriatic arthritis	4.54e-05	0.000532	CcSEcCtD
Cyclosporine—Pain—Betamethasone—psoriatic arthritis	4.54e-05	0.000532	CcSEcCtD
Cyclosporine—Nervous system disorder—Prednisone—psoriatic arthritis	4.54e-05	0.000531	CcSEcCtD
Cyclosporine—Skin disorder—Prednisone—psoriatic arthritis	4.49e-05	0.000526	CcSEcCtD
Cyclosporine—Hyperhidrosis—Prednisone—psoriatic arthritis	4.47e-05	0.000523	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—psoriatic arthritis	4.46e-05	0.000523	CcSEcCtD
Cyclosporine—Anorexia—Prednisone—psoriatic arthritis	4.41e-05	0.000516	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—psoriatic arthritis	4.4e-05	0.000514	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—psoriatic arthritis	4.38e-05	0.000512	CcSEcCtD
Cyclosporine—Feeling abnormal—Dexamethasone—psoriatic arthritis	4.38e-05	0.000512	CcSEcCtD
Cyclosporine—Feeling abnormal—Betamethasone—psoriatic arthritis	4.38e-05	0.000512	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	4.34e-05	0.000508	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	4.34e-05	0.000508	CcSEcCtD
Cyclosporine—Hypersensitivity—Triamcinolone—psoriatic arthritis	4.31e-05	0.000505	CcSEcCtD
Cyclosporine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	4.3e-05	0.000504	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—psoriatic arthritis	4.27e-05	0.0005	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—psoriatic arthritis	4.26e-05	0.000498	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—psoriatic arthritis	4.24e-05	0.000496	CcSEcCtD
Cyclosporine—Urticaria—Betamethasone—psoriatic arthritis	4.22e-05	0.000494	CcSEcCtD
Cyclosporine—Urticaria—Dexamethasone—psoriatic arthritis	4.22e-05	0.000494	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	4.21e-05	0.000493	CcSEcCtD
Cyclosporine—Dizziness—Prednisolone—psoriatic arthritis	4.21e-05	0.000493	CcSEcCtD
Cyclosporine—Asthenia—Triamcinolone—psoriatic arthritis	4.2e-05	0.000492	CcSEcCtD
Cyclosporine—Abdominal pain—Dexamethasone—psoriatic arthritis	4.2e-05	0.000491	CcSEcCtD
Cyclosporine—Abdominal pain—Betamethasone—psoriatic arthritis	4.2e-05	0.000491	CcSEcCtD
Cyclosporine—Body temperature increased—Dexamethasone—psoriatic arthritis	4.2e-05	0.000491	CcSEcCtD
Cyclosporine—Body temperature increased—Betamethasone—psoriatic arthritis	4.2e-05	0.000491	CcSEcCtD
Cyclosporine—Asthenia—Methylprednisolone—psoriatic arthritis	4.19e-05	0.000491	CcSEcCtD
Cyclosporine—Insomnia—Prednisone—psoriatic arthritis	4.18e-05	0.00049	CcSEcCtD
Cyclosporine—Paraesthesia—Prednisone—psoriatic arthritis	4.15e-05	0.000486	CcSEcCtD
Cyclosporine—Pruritus—Triamcinolone—psoriatic arthritis	4.14e-05	0.000485	CcSEcCtD
Cyclosporine—Cough—Methotrexate—psoriatic arthritis	4.13e-05	0.000484	CcSEcCtD
Cyclosporine—Pruritus—Methylprednisolone—psoriatic arthritis	4.13e-05	0.000484	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—psoriatic arthritis	4.1e-05	0.00048	CcSEcCtD
Cyclosporine—Dyspepsia—Prednisone—psoriatic arthritis	4.07e-05	0.000477	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—psoriatic arthritis	4.03e-05	0.000472	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—psoriatic arthritis	4.03e-05	0.000472	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—psoriatic arthritis	4.03e-05	0.000472	CcSEcCtD
Cyclosporine—Decreased appetite—Prednisone—psoriatic arthritis	4.02e-05	0.000471	CcSEcCtD
Cyclosporine—Rash—Prednisolone—psoriatic arthritis	4.01e-05	0.00047	CcSEcCtD
Cyclosporine—Dermatitis—Prednisolone—psoriatic arthritis	4.01e-05	0.000469	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	4e-05	0.000469	CcSEcCtD
Cyclosporine—Diarrhoea—Methylprednisolone—psoriatic arthritis	4e-05	0.000468	CcSEcCtD
Cyclosporine—Fatigue—Prednisone—psoriatic arthritis	3.99e-05	0.000467	CcSEcCtD
Cyclosporine—Headache—Prednisolone—psoriatic arthritis	3.99e-05	0.000467	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—psoriatic arthritis	3.98e-05	0.000466	CcSEcCtD
Cyclosporine—Constipation—Prednisone—psoriatic arthritis	3.96e-05	0.000463	CcSEcCtD
Cyclosporine—Confusional state—Methotrexate—psoriatic arthritis	3.9e-05	0.000456	CcSEcCtD
Cyclosporine—Dizziness—Triamcinolone—psoriatic arthritis	3.87e-05	0.000453	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—psoriatic arthritis	3.87e-05	0.000452	CcSEcCtD
Cyclosporine—Dizziness—Methylprednisolone—psoriatic arthritis	3.86e-05	0.000452	CcSEcCtD
Cyclosporine—Infection—Methotrexate—psoriatic arthritis	3.84e-05	0.00045	CcSEcCtD
Cyclosporine—Feeling abnormal—Prednisone—psoriatic arthritis	3.81e-05	0.000446	CcSEcCtD
Cyclosporine—Asthenia—Dexamethasone—psoriatic arthritis	3.81e-05	0.000446	CcSEcCtD
Cyclosporine—Asthenia—Betamethasone—psoriatic arthritis	3.81e-05	0.000446	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—psoriatic arthritis	3.79e-05	0.000444	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—psoriatic arthritis	3.79e-05	0.000443	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Prednisone—psoriatic arthritis	3.78e-05	0.000443	CcSEcCtD
Cyclosporine—Nausea—Prednisolone—psoriatic arthritis	3.78e-05	0.000443	CcSEcCtD
Cyclosporine—Pruritus—Dexamethasone—psoriatic arthritis	3.76e-05	0.00044	CcSEcCtD
Cyclosporine—Pruritus—Betamethasone—psoriatic arthritis	3.76e-05	0.00044	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—psoriatic arthritis	3.76e-05	0.00044	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—psoriatic arthritis	3.74e-05	0.000437	CcSEcCtD
Cyclosporine—Vomiting—Triamcinolone—psoriatic arthritis	3.72e-05	0.000436	CcSEcCtD
Cyclosporine—Vomiting—Methylprednisolone—psoriatic arthritis	3.71e-05	0.000435	CcSEcCtD
Cyclosporine—Rash—Triamcinolone—psoriatic arthritis	3.69e-05	0.000432	CcSEcCtD
Cyclosporine—Dermatitis—Triamcinolone—psoriatic arthritis	3.69e-05	0.000432	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—psoriatic arthritis	3.69e-05	0.000431	CcSEcCtD
Cyclosporine—Rash—Methylprednisolone—psoriatic arthritis	3.68e-05	0.000431	CcSEcCtD
Cyclosporine—Dermatitis—Methylprednisolone—psoriatic arthritis	3.68e-05	0.000431	CcSEcCtD
Cyclosporine—Urticaria—Prednisone—psoriatic arthritis	3.67e-05	0.00043	CcSEcCtD
Cyclosporine—Headache—Triamcinolone—psoriatic arthritis	3.67e-05	0.000429	CcSEcCtD
Cyclosporine—Headache—Methylprednisolone—psoriatic arthritis	3.66e-05	0.000428	CcSEcCtD
Cyclosporine—Abdominal pain—Prednisone—psoriatic arthritis	3.66e-05	0.000428	CcSEcCtD
Cyclosporine—Body temperature increased—Prednisone—psoriatic arthritis	3.66e-05	0.000428	CcSEcCtD
Cyclosporine—Diarrhoea—Betamethasone—psoriatic arthritis	3.63e-05	0.000425	CcSEcCtD
Cyclosporine—Diarrhoea—Dexamethasone—psoriatic arthritis	3.63e-05	0.000425	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	3.52e-05	0.000412	CcSEcCtD
Cyclosporine—Dizziness—Dexamethasone—psoriatic arthritis	3.51e-05	0.000411	CcSEcCtD
Cyclosporine—Dizziness—Betamethasone—psoriatic arthritis	3.51e-05	0.000411	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—psoriatic arthritis	3.5e-05	0.000409	CcSEcCtD
Cyclosporine—Nausea—Triamcinolone—psoriatic arthritis	3.48e-05	0.000407	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—psoriatic arthritis	3.47e-05	0.000406	CcSEcCtD
Cyclosporine—Nausea—Methylprednisolone—psoriatic arthritis	3.47e-05	0.000406	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—psoriatic arthritis	3.45e-05	0.000403	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—psoriatic arthritis	3.44e-05	0.000402	CcSEcCtD
Cyclosporine—Hypersensitivity—Prednisone—psoriatic arthritis	3.41e-05	0.000399	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—psoriatic arthritis	3.4e-05	0.000398	CcSEcCtD
Cyclosporine—Vomiting—Betamethasone—psoriatic arthritis	3.38e-05	0.000395	CcSEcCtD
Cyclosporine—Vomiting—Dexamethasone—psoriatic arthritis	3.38e-05	0.000395	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—psoriatic arthritis	3.36e-05	0.000393	CcSEcCtD
Cyclosporine—Rash—Betamethasone—psoriatic arthritis	3.35e-05	0.000392	CcSEcCtD
Cyclosporine—Rash—Dexamethasone—psoriatic arthritis	3.35e-05	0.000392	CcSEcCtD
Cyclosporine—Dermatitis—Dexamethasone—psoriatic arthritis	3.35e-05	0.000392	CcSEcCtD
Cyclosporine—Dermatitis—Betamethasone—psoriatic arthritis	3.35e-05	0.000392	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	3.34e-05	0.000391	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—psoriatic arthritis	3.33e-05	0.00039	CcSEcCtD
Cyclosporine—Headache—Betamethasone—psoriatic arthritis	3.33e-05	0.000389	CcSEcCtD
Cyclosporine—Headache—Dexamethasone—psoriatic arthritis	3.33e-05	0.000389	CcSEcCtD
Cyclosporine—Asthenia—Prednisone—psoriatic arthritis	3.32e-05	0.000388	CcSEcCtD
Cyclosporine—Pain—Methotrexate—psoriatic arthritis	3.31e-05	0.000387	CcSEcCtD
Cyclosporine—Pruritus—Prednisone—psoriatic arthritis	3.27e-05	0.000383	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—psoriatic arthritis	3.19e-05	0.000373	CcSEcCtD
Cyclosporine—Diarrhoea—Prednisone—psoriatic arthritis	3.16e-05	0.00037	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	3.16e-05	0.00037	CcSEcCtD
Cyclosporine—Nausea—Dexamethasone—psoriatic arthritis	3.16e-05	0.000369	CcSEcCtD
Cyclosporine—Nausea—Betamethasone—psoriatic arthritis	3.16e-05	0.000369	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—psoriatic arthritis	3.07e-05	0.000359	CcSEcCtD
Cyclosporine—Dizziness—Prednisone—psoriatic arthritis	3.06e-05	0.000358	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—psoriatic arthritis	3.06e-05	0.000358	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—psoriatic arthritis	3.06e-05	0.000358	CcSEcCtD
Cyclosporine—Vomiting—Prednisone—psoriatic arthritis	2.94e-05	0.000344	CcSEcCtD
Cyclosporine—Rash—Prednisone—psoriatic arthritis	2.92e-05	0.000341	CcSEcCtD
Cyclosporine—Dermatitis—Prednisone—psoriatic arthritis	2.91e-05	0.000341	CcSEcCtD
Cyclosporine—Headache—Prednisone—psoriatic arthritis	2.9e-05	0.000339	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—psoriatic arthritis	2.85e-05	0.000333	CcSEcCtD
Cyclosporine—Asthenia—Methotrexate—psoriatic arthritis	2.77e-05	0.000325	CcSEcCtD
Cyclosporine—Nausea—Prednisone—psoriatic arthritis	2.75e-05	0.000322	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—psoriatic arthritis	2.74e-05	0.00032	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—psoriatic arthritis	2.65e-05	0.00031	CcSEcCtD
Cyclosporine—Dizziness—Methotrexate—psoriatic arthritis	2.56e-05	0.000299	CcSEcCtD
Cyclosporine—Vomiting—Methotrexate—psoriatic arthritis	2.46e-05	0.000288	CcSEcCtD
Cyclosporine—Rash—Methotrexate—psoriatic arthritis	2.44e-05	0.000285	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—psoriatic arthritis	2.44e-05	0.000285	CcSEcCtD
Cyclosporine—Headache—Methotrexate—psoriatic arthritis	2.42e-05	0.000283	CcSEcCtD
Cyclosporine—Nausea—Methotrexate—psoriatic arthritis	2.3e-05	0.000269	CcSEcCtD
